Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV-ICD
---
identifier: "/us/fr/C1-2026-02383"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV-ICD"
title_number: 0
title_name: "Federal Register"
section_number: "C1-2026-02383"
section_name: "Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV-ICD"
positive_law: false
currency: "2026-03-10"
last_updated: "2026-03-10"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "C1-2026-02383"
document_type: "notice"
publication_date: "2026-03-10"
agencies:
- "Health and Human Services Department"
- "Food and Drug Administration"
fr_citation: "91 FR 11557"
fr_volume: 91
docket_ids:
- "Docket Nos. FDA-2024-E-3535 and FDA-2024-E-3536"
---
# Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV-ICD
**Correction**
In Notice Document 2026-02383, appearing on pages 5497 through 5498, in the issue of Friday, February 6, 2026, make the following correction:
On page 5497, in the second column, in the *ADDRESSES* section, in the 8th line, “February 6, 2026” should read “April 7, 2026”.